JD-5037
10mM in DMSO
- Product Code: 201282
CAS:
1392116-14-1
| Molecular Weight: | 572.51 g./mol | Molecular Formula: | C₂₇H₂₇Cl₂N₅O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in research for treating metabolic disorders, JD-5037 acts as a cannabinoid receptor 1 (CB1) inverse agonist. It helps regulate appetite and improve insulin sensitivity, making it a candidate for studying obesity and type 2 diabetes. Due to its peripheral restriction, it minimizes central nervous system side effects, which were a concern with earlier CB1 antagonists. Studies show it can reduce food intake, body weight, and improve glucose tolerance in animal models. It is not used clinically and remains a tool compound for understanding metabolic disease pathways.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | ฿6,480.00 |
+
-
|
JD-5037
Used in research for treating metabolic disorders, JD-5037 acts as a cannabinoid receptor 1 (CB1) inverse agonist. It helps regulate appetite and improve insulin sensitivity, making it a candidate for studying obesity and type 2 diabetes. Due to its peripheral restriction, it minimizes central nervous system side effects, which were a concern with earlier CB1 antagonists. Studies show it can reduce food intake, body weight, and improve glucose tolerance in animal models. It is not used clinically and remains a tool compound for understanding metabolic disease pathways.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :